SubsidieMeestersNeuroClues: the clinical must-have for Neurologists: clinical validation, industrialization, and go-to-market.
NeuroClues is a portable eye tracking device aimed at accelerating and improving the diagnosis of movement disorders for neurologists, with plans for clinical validation and market readiness by 2024.
Projectdetails
Introduction
P3Lab developed NeuroClues, a first-of-a-kind portable, fast, and easy-to-use eye tracking medical device that brings clinically validated eye movement biomarkers for movement disorders (MDs) into the clinical routine of neurologists.
Objectives
NeuroClues will enable neurologists to establish their MD diagnosis faster (from months to days), earlier, and more reliably, with diagnostic grade accuracy. This will enable neurologists to start patient care earlier.
Project Aims
This project aims at validating and demonstrating:
- The usability of NeuroClues in the clinical routine with early adopter KOL neurologists.
- Its clinical value in ongoing studies.
- Its clinical value in own sponsored clinical investigation studies (EU and US).
Importance
This validation is needed to convince the broad majority of neurologists of NeuroClues’ clinical value.
Future Goals
The successful demonstration and accompanied development of our go-to-market strategy will enable P3Lab to become investor ready by 2024 and profitable by 2027, with €70M ARR targeted by 2030.
Financiële details & Tijdlijn
Financiële details
| Subsidiebedrag | € 2.500.000 |
| Totale projectbegroting | € 5.557.786 |
Tijdlijn
| Startdatum | 1-2-2023 |
| Einddatum | 31-1-2027 |
| Subsidiejaar | 2023 |
Partners & Locaties
Projectpartners
- P3 LABpenvoerder
Land(en)
Vergelijkbare projecten binnen EIC Accelerator
| Project | Regeling | Bedrag | Jaar | Actie |
|---|---|---|---|---|
“EEG-based DIagnosis Support solutiON” (EDISON) to help close the epilepsy diagnosis gap in Low- and Middle-Income Countries (LMICs) by combining low CAPEX and AI-guided capture with telemedicineBrainCapture is developing an affordable EEG-based diagnosis service for epilepsy in LMICs, utilizing mobile technology and AI for remote analysis by neurologists to improve access to care. | EIC Accelerator | € 2.078.428 | 2022 | Details |
"The NIMBLE System: A novel non-invasive and non-ionizing medical device for the continous monitoring of patients with implanted cardiovascular stents"""NIMBLE Diagnostics is developing a microwave-based device for non-invasive stent monitoring, aiming to shift from reactive to proactive care and improve patient outcomes. | EIC Accelerator | € 2.306.500 | 2024 | Details |
Brain Interchange ONE SR—the implantable neuromodulation technology for stroke rehabilitationCorTec aims to develop innovative implantable technology for stroke rehabilitation, enabling new therapies and devices while targeting market approval and $250M in sales by 2030. | EIC Accelerator | € 2.500.000 | 2022 | Details |
Paradigm shift in stroke: accurate diagnosis and evaluation of all treatment options in any hospital, at any timeMethinks aims to transform stroke diagnosis by enabling all hospitals to evaluate treatment options using standard imaging, reducing time-to-treatment and improving patient outcomes globally. | EIC Accelerator | € 2.495.415 | 2023 | Details |
“EEG-based DIagnosis Support solutiON” (EDISON) to help close the epilepsy diagnosis gap in Low- and Middle-Income Countries (LMICs) by combining low CAPEX and AI-guided capture with telemedicine
BrainCapture is developing an affordable EEG-based diagnosis service for epilepsy in LMICs, utilizing mobile technology and AI for remote analysis by neurologists to improve access to care.
"The NIMBLE System: A novel non-invasive and non-ionizing medical device for the continous monitoring of patients with implanted cardiovascular stents"""
NIMBLE Diagnostics is developing a microwave-based device for non-invasive stent monitoring, aiming to shift from reactive to proactive care and improve patient outcomes.
Brain Interchange ONE SR—the implantable neuromodulation technology for stroke rehabilitation
CorTec aims to develop innovative implantable technology for stroke rehabilitation, enabling new therapies and devices while targeting market approval and $250M in sales by 2030.
Paradigm shift in stroke: accurate diagnosis and evaluation of all treatment options in any hospital, at any time
Methinks aims to transform stroke diagnosis by enabling all hospitals to evaluate treatment options using standard imaging, reducing time-to-treatment and improving patient outcomes globally.
Vergelijkbare projecten uit andere regelingen
| Project | Regeling | Bedrag | Jaar | Actie |
|---|---|---|---|---|
A novel approach for the phenotype characterization of neurological pediatric movement disordersHet project ontwikkelt een niet-invasieve AI-gestuurde oogvolgtechnologie voor de objectieve diagnose van pediatrische bewegingsstoornissen, met als doel nauwkeurige en gepersonaliseerde behandelingen te verbeteren. | Mkb-innovati... | € 18.114 | 2021 | Details |
Data4NeuroData4Neuro ontwikkelt een datagedreven platform voor de neurosurgische industrie om realtime feedback van clinici te verzamelen en inzichten te bieden. | Mkb-innovati... | € 20.000 | 2021 | Details |
Signal-enhanced MRI contrast agents for neurodegenerationThis project aims to develop and validate new magnetic resonance technologies for early, non-invasive diagnosis of neurodegenerative diseases using metabolic contrast agents. | ERC Proof of... | € 150.000 | 2022 | Details |
Accurate quantification of neurologic disease over timeThe project aims to develop CHRONOS, an AI-driven diagnostic tool using synthetic biomaps to enable earlier and more accurate detection of brain tumors, facilitating timely clinical decisions. | ERC Proof of... | € 150.000 | 2025 | Details |
Preclinical in vivo validation of a glioblastoma neuro snooper electrical deviceThis project aims to develop and validate the 'GBM Neuro Snooper' device to improve understanding and treatment of glioblastoma by assessing brain electrophysiology post-tumor resection. | ERC Proof of... | € 150.000 | 2023 | Details |
A novel approach for the phenotype characterization of neurological pediatric movement disorders
Het project ontwikkelt een niet-invasieve AI-gestuurde oogvolgtechnologie voor de objectieve diagnose van pediatrische bewegingsstoornissen, met als doel nauwkeurige en gepersonaliseerde behandelingen te verbeteren.
Data4Neuro
Data4Neuro ontwikkelt een datagedreven platform voor de neurosurgische industrie om realtime feedback van clinici te verzamelen en inzichten te bieden.
Signal-enhanced MRI contrast agents for neurodegeneration
This project aims to develop and validate new magnetic resonance technologies for early, non-invasive diagnosis of neurodegenerative diseases using metabolic contrast agents.
Accurate quantification of neurologic disease over time
The project aims to develop CHRONOS, an AI-driven diagnostic tool using synthetic biomaps to enable earlier and more accurate detection of brain tumors, facilitating timely clinical decisions.
Preclinical in vivo validation of a glioblastoma neuro snooper electrical device
This project aims to develop and validate the 'GBM Neuro Snooper' device to improve understanding and treatment of glioblastoma by assessing brain electrophysiology post-tumor resection.